相似文献
1
Five years' experience with ChlVPP: effective low-toxicity combination chemotherapy for Hodgkin's disease.
Br J Cancer. 1982 Jun;45(6):851-9. doi: 10.1038/bjc.1982.137.
2
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.
Br J Cancer. 1977 Aug;36(2):276-80. doi: 10.1038/bjc.1977.187.
3
Three years' experience with Ch1VPP (a combination of drugs of low toxicity) for the treatment of Hodgkin's disease.
Br J Cancer. 1979 Feb;39(2):168-74. doi: 10.1038/bjc.1979.27.
4
ChlVPP chemotherapy in advanced Hodgkin's disease.
Eur J Cancer Clin Oncol. 1989 Mar;25(3):557-61. doi: 10.1016/0277-5379(89)90270-8.
5
ChlVPP therapy for Hodgkin's disease: experience of 960 patients. The International ChlVPP Treatment Group.
Ann Oncol. 1995 Feb;6(2):167-72.
6
ChlVPP combination chemotherapy for Hodgkin's disease: long-term results.
Br J Cancer. 1990 Aug;62(2):279-85. doi: 10.1038/bjc.1990.278.
7
ChlVPP alternating with PABlOE is superior to PABlOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial.
Br J Cancer. 2001 May 18;84(10):1293-300. doi: 10.1054/bjoc.2001.1778.
8
ChlVPP/EVA hybrid versus the weekly VAPEC-B regimen for previously untreated Hodgkin's disease.
J Clin Oncol. 2002 Jul 1;20(13):2988-94. doi: 10.1200/JCO.2002.11.107.
9
OPEC chemotherapy (vincristine, prednisolone, etoposide and chlorambucil) for refractory and recurrent Hodgkin's disease.
Hematol Oncol. 1987 Apr-Jun;5(2):79-82. doi: 10.1002/hon.2900050202.
10
CHLVPP chemotherapy with involved-field irradiation for Hodgkin's disease: favorable results with acceptable toxicity.
J Clin Oncol. 1991 Aug;9(8):1421-5. doi: 10.1200/JCO.1991.9.8.1421.
引用本文的文献
1
The lymphomas--current management.
Postgrad Med J. 1983 Apr;59(690):219-28. doi: 10.1136/pgmj.59.690.219.
2
Current management of Hodgkin's disease.
Drugs. 1985 Oct;30(4):355-67. doi: 10.2165/00003495-198530040-00004.
3
ChlVPP combination chemotherapy for Hodgkin's disease: long-term results.
Br J Cancer. 1990 Aug;62(2):279-85. doi: 10.1038/bjc.1990.278.
4
VIM-D salvage chemotherapy in Hodgkin's disease.
Cancer Chemother Pharmacol. 1990;27(2):161-3. doi: 10.1007/BF00689103.
本文引用的文献
1
Mediastinal involvement in early-stage Hodgkin's disease. Response to treatment and pattern of relapse.
Eur J Cancer (1965). 1980 Aug;16(8):1065-8. doi: 10.1016/0014-2964(80)90254-6.
2
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.
Ann Intern Med. 1980 May;92(5):587-95. doi: 10.7326/0003-4819-92-5-587.
3
Studies on the mechanism of radiation-induced leukemogenesis in C57BL mice.
Cancer Res. 1966 Mar;26(3):395-9.
4
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
Ann Intern Med. 1970 Dec;73(6):881-95. doi: 10.7326/0003-4819-73-6-881.
5
Report of the Committee on Hodgkin's Disease Staging Classification.
Cancer Res. 1971 Nov;31(11):1860-1.
6
Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
Ann Intern Med. 1973 Sep;79(3):376-82. doi: 10.7326/0003-4819-79-3-376.
7
Combination chemotherapy in advanced and recurrent Hodgkin's disease.
Natl Cancer Inst Monogr. 1973 May;36:395-402.
8
A combination of chlorambucil, vinblastine, procarbazine and prednisolone for treatment of Hodgkin's disease.
Br J Cancer. 1977 Aug;36(2):276-80. doi: 10.1038/bjc.1977.187.
9
Hodgkin's disease in children.
Br J Cancer. 1977 Jul;36(1):120-9. doi: 10.1038/bjc.1977.162.
10
MVPP chemotherapy regimen for advanced Hodgkin's disease.
Br Med J. 1978 Mar 18;1(6114):679-83. doi: 10.1136/bmj.1.6114.679.
Zotero 插件